A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

RECRUITING

UZ Gent ( Site 3428), Ghent

RECRUITING

National Taiwan University Hospital ( Site 3983), Taiwan

RECRUITING

New York Medical College ( Site 3023), Valhalla

RECRUITING

Children's Hospital of Philadelphia (CHOP) ( Site 3021), Philadelphia

RECRUITING

Hospital Infantil Universitario Nino Jesus ( Site 3715), Madrid

RECRUITING

Bordeaux University Hospital - Pellegrin ( Site 3105), Bordeaux

RECRUITING

Centre Hospitalier Universitaire de Nantes - Hôpital Femme-Enfant-Adolescent Chu De Nantes ( Site 3104), Nantes

RECRUITING

University of Iowa Health Care Holden Comprehensive Cancer Center ( Site 3017), Iowa City

RECRUITING

Sanford Children's Hospital ( Site 3015), Sioux Falls

RECRUITING

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 3003), Fargo

RECRUITING

Centre Leon-Berard ( Site 3100), Lyon

RECRUITING

University of Texas-MD Anderson Cancer Center ( Site 3007), Houston

RECRUITING

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 3016), Aurora

RECRUITING

Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City

RECRUITING

Sheba Medical Center ( Site 3675), Ramat Gan

RECRUITING

Rutgers Cancer Institute of New Jersey ( Site 3008), New Brunswick

RECRUITING

Seoul National University Hospital-Pediatrics ( Site 3972), Seoul

RECRUITING

Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 3973), Seoul

RECRUITING

Hospital Sant Joan de Déu ( Site 3717), Esplugues de Llobregat

RECRUITING

Hospital Universitari Vall d''Hebron ( Site 3716), Barcelona

RECRUITING

Sahlgrenska Universitetssjukhuset. ( Site 3634), Gothenburg

RECRUITING

Royal Victoria Infirmary ( Site 3348), Newcastle upon Tyne